The $500 million deal will expand CareFusion’s Specialty Disposables business by adding more distribution channels and new anesthesiology products. Vital Signs will be CareFusion’s eighth acquisition since 2010.
“The acquisition of Vital Signs is well-aligned to our long-term growth strategy, helping us create scale in our Procedural Solutions call points and increas[ing] our presence outside of the United States,” said Kieran T. Gallahue, chairman and CEO of CareFusion, in a news release. “Together, CareFusion and Vital Signs have the [research and development], manufacturing and go-to-market resources to drive innovation, invest for growth and better support customers in major geographic markets.”
More Articles on the Health IT Market:
Allscripts Reports 3Q Loss
Experian Acquires Passport Health Communications for $850M
Health IT M&A Activity: MEDSEEK Acquires SymphonyCare, WebMD Acquires Avado
